Literature DB >> 23974638

Cytisine, the world's oldest smoking cessation aid.

Judith J Prochaska, Smita Das, Neal L Benowitz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23974638     DOI: 10.1136/bmj.f5198

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  11 in total

Review 1.  The biological and clinical effects of smoking by patients with cancer and strategies to implement evidence-based tobacco cessation support.

Authors:  Graham W Warren; Samantha Sobus; Ellen R Gritz
Journal:  Lancet Oncol       Date:  2014-10-26       Impact factor: 41.316

Review 2.  Innovative approaches to support smoking cessation for individuals with mental illness and co-occurring substance use disorders.

Authors:  Smita Das; Judith J Prochaska
Journal:  Expert Rev Respir Med       Date:  2017-08-09       Impact factor: 3.772

3.  Cytisine inhibits the protective activity of various classical and novel antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice.

Authors:  Piotr Tutka; Maria W Kondrat-Wróbel; Katarzyna Zaluska; Dorota Żółkowska; Magdalena Florek-Łuszczki; Jarogniew J Łuszczki
Journal:  Psychopharmacology (Berl)       Date:  2016-10-25       Impact factor: 4.530

Review 4.  The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data.

Authors:  Hans Rollema; Raymond S Hurst
Journal:  Psychopharmacology (Berl)       Date:  2018-07-07       Impact factor: 4.530

Review 5.  Discovery and development of varenicline for smoking cessation.

Authors:  Chloe J Jordan; Zheng-Xiong Xi
Journal:  Expert Opin Drug Discov       Date:  2018-03-28       Impact factor: 6.098

6.  The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial.

Authors:  Omara Dogar; Deepa Barua; Melanie Boeckmann; Helen Elsey; Razia Fatima; Rhian Gabe; Rumana Huque; Ada Keding; Amina Khan; Daniel Kotz; Eva Kralikova; James N Newell; Iveta Nohavova; Steve Parrott; Anne Readshaw; Lottie Renwick; Aziz Sheikh; Kamran Siddiqi
Journal:  Addiction       Date:  2018-04-20       Impact factor: 6.526

Review 7.  Orthosteric and Allosteric Ligands of Nicotinic Acetylcholine Receptors for Smoking Cessation.

Authors:  Tasnim S Mohamed; Selwyn S Jayakar; Ayman K Hamouda
Journal:  Front Mol Neurosci       Date:  2015-11-25       Impact factor: 5.639

Review 8.  Role of nicotine receptor partial agonists in tobacco cessation.

Authors:  Nivedita Maity; Prabhat Chand; Pratima Murthy
Journal:  Indian J Psychiatry       Date:  2014-01       Impact factor: 1.759

9.  Semisynthetic analogues of toxiferine I and their pharmacological properties at α7 nAChRs, muscle-type nAChRs, and the allosteric binding site of muscarinic M2 receptors.

Authors:  Darius P Zlotos; Christian Tränkle; Ulrike Holzgrabe; Daniela Gündisch; Anders A Jensen
Journal:  J Nat Prod       Date:  2014-09-05       Impact factor: 4.050

10.  Cytisine versus varenicline for smoking cessation for Māori (the indigenous people of New Zealand) and their extended family: protocol for a randomized non-inferiority trial.

Authors:  Natalie Walker; Barry Smith; Joanne Barnes; Marjolein Verbiest; Tomasz Kurdziel; Varsha Parag; Subhash Pokhrel; Chris Bullen
Journal:  Addiction       Date:  2018-11-09       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.